Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-01-501864
Filing Date
2001-06-29
Accepted
2001-06-29 00:00:00
Documents
8
Period of Report
2001-03-31

Document Format Files

Seq Description Document Type Size
1 ALKERMES, INC. b39823aie10-k405.txt 10-K405 290089
2 THIRD AMENDED AND RESTATED ARTICLES OF INC. b39823aiex3-1.txt EX-3.1 13461
3 AMENDED AND RESTATED BY-LAWS OF ALKERMES, INC. b39823aiex3-2.txt EX-3.2 29651
4 1999 STOCK OPTION PLAN b39823aiex10-7.txt EX-10.7 30879
5 MANUFACTURE AND SUPPLY AGREEMENT b39823aiex10-16.txt EX-10.16 65963
6 EMPLOYMENT AGREEMENT b39823aiex10-32.txt EX-10.32 9461
7 SUBSIDIARIES OF THE REGISTRANT b39823aiex21.txt EX-21 1288
8 CONSENT OF DELOITTE & TOUCHE LLP b39823aiex23.txt EX-23 656
  Complete submission text file 0000950135-01-501864.txt   443741
Mailing Address
Business Address 64 SIDNEY ST CAMBRIDGE MA 02139-4136 6174940171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K405 | Act: 34 | File No.: 001-14131 | Film No.: 1672357
SIC: 2834 Pharmaceutical Preparations